Department of Clinical Laboratory, Baodi District People's Hospital, Tianjin 301800, P.R. China.
Mol Med Rep. 2019 Oct;20(4):3395-3405. doi: 10.3892/mmr.2019.10584. Epub 2019 Aug 9.
Cerebral ischemic injury is a major cause of death and long‑term disability worldwide that leads to neurological and behavioral deficits, and for which successful treatments are still lacking. Ras homolog family member A (RhoA) and Rho‑associated coiled‑coil containing protein kinase (ROCK) are associated with the growth of neurons and the movement of neuronal growth cones. RhoA/ROCK inhibitors have been demonstrated to promote the recovery of motor function following nerve injury, but the underlying mechanism requires further investigation. The present study aimed to investigate the effects of the ROCK inhibitor Y‑27632 on middle cerebral artery occlusion (MCAO)‑induced cerebral ischemic injury. Rats were randomly assigned to the Control, Y‑27632, MCAO + Vehicle or MCAO + Y‑27632 group. Firstly, infarct volume, cognitive ability and cerebral injury were assessed. Secondly, indicators of cerebral inflammation, oxidative stress and apoptosis were evaluated. Finally, the expression of recombinant glial fibrillary acidic protein (GFAP) and allograft inflammatory factor 1 (AIF1) in the brain were measured to assess the activation of astrocytes and microglia, respectively. The results showed that Y‑27632 effectively increased the survival rate and behavioral performance of rats, and attenuated the cerebral injury, oxidative stress and cerebral inflammation levels following MCAO. The disturbance in hippocampal neurons caused by MCAO was also alleviated following treatment with Y‑27632. Neuronal apoptosis was also decreased following Y‑27632 treatment, as demonstrated by the TUNEL assay and the expression levels of Caspases‑3, 8 and 9 and Bax/Bcl‑2 ratio. The levels of GFAP and AIF1 were increased by MCAO and further promoted by Y‑27632, indicating the activation of astrocytes and microglia. In conclusion, the present study offered evidence of a protective effect of Y‑27632 administration on cerebral ischemia/reperfusion induced behavioral and hippocampal damage by activating astrocytes and microglia.
脑缺血性损伤是全球范围内导致神经和行为缺陷的主要死亡和长期致残原因,目前仍缺乏有效的治疗方法。Ras 同源家族成员 A(RhoA)和Rho 相关卷曲螺旋蛋白激酶(ROCK)与神经元的生长和神经元生长锥的运动有关。已经证明 RhoA/ROCK 抑制剂可促进神经损伤后运动功能的恢复,但潜在机制仍需进一步研究。本研究旨在探讨 ROCK 抑制剂 Y-27632 对大脑中动脉闭塞(MCAO)诱导的脑缺血性损伤的影响。大鼠随机分为对照组、Y-27632 组、MCAO+Vehicle 组和 MCAO+Y-27632 组。首先评估梗死体积、认知能力和脑损伤。其次,评估脑炎症、氧化应激和细胞凋亡的指标。最后,测量脑内重组胶质纤维酸性蛋白(GFAP)和同种异体炎症因子 1(AIF1)的表达,以分别评估星形胶质细胞和小胶质细胞的激活。结果表明,Y-27632 可有效提高大鼠的存活率和行为表现,减轻 MCAO 后大脑损伤、氧化应激和脑炎症水平。MCAO 引起的海马神经元紊乱也在 Y-27632 治疗后得到缓解。TUNEL 检测和 Caspases-3、8 和 9 及 Bax/Bcl-2 比值的表达水平均表明,Y-27632 治疗后神经元凋亡减少。MCAO 后 GFAP 和 AIF1 水平升高,进一步促进了 Y-27632 的表达,表明星形胶质细胞和小胶质细胞被激活。综上所述,本研究提供了证据表明,通过激活星形胶质细胞和小胶质细胞,Y-27632 给药对脑缺血再灌注引起的行为和海马损伤具有保护作用。